GlycoNex Competitors and Similar CompaniesClear all
GlycoNex's competitors and similar companies include CytomX Therapeutics.
 GlycoNex GlycoNex (台灣醣聯生技醫藥股) is a company developing cancer drugs utilizing glycosphingolipid antigen and human monoclonal antibody technologies. |  CytomX Therapeutics CytomX is an oncology-focused biopharmaceutical company pioneering a novel class of antibody therapeutics based on Probody technology platform. | |
Founding Date | Founding Date 2001 | Founding Date 2008 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations TW HQ | Locations South San Francisco, US HQ |
Employees | Employees N/A | Employees 15815% increase |
Financial | ||
Revenue (est.) | Revenue (est.) NT$37.9m (FY, 2025) | Revenue (est.) $76.2m (FY, 2025) |
Net income | Net income (NT$235.2m) (FY, 2025) | Net income ($17.4m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
CytomX Therapeutics
HQ
South San Francisco, US
Employees
158↑ 15% increase
CytomX is an oncology-focused biopharmaceutical company pioneering a novel class of antibody therapeutics based on Probody technology platform.
View company